precision-diagnostics
(2)
Liz O’Day Put Science on a T-Shirt. Then She Put It on a Deadline.
Before Olaris, Liz O’Day stored science-themed shirts in her kitchen and quietly wondered whether she counted as an entrepreneur. Twelve years into building a diagnostics company, the answer lives in her habit of turning difficult questions into things people can actually use.
Russ Lebovitz
Russ Lebovitz is the co-founder and CEO of Amprion, a precision brain diagnostics company that built the first commercial seed amplification assay for detecting misfolded alpha-synuclein - the protein at the root of Parkinson's disease and other synucleinopathies. An MD/PhD trained at Washington University in St. Louis and a former research physician at Baylor and Fox Chase Cancer Center, Lebovitz spent years chasing prions after the mad cow scare, then pivoted the same detection science toward common neurodegenerative diseases. His SYNTap test won an FDA Breakthrough Device Designation and is now used in clinical trials and patient care to spot brain disease years before symptoms appear.